Cargando…
Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring?
The intact parathyroid hormone (iPTH) assay is a critical test in the diagnosis and management of PTH-mediated hypercalcemia, including parathyroid carcinoma (PCa). We hypothesized that the survival of patients diagnosed with PCa has improved since adoption of the iPTH assay into clinical practice....
Autores principales: | Allen, Miya E., Semrad, Alison, Yang, Anthony D., Martinez, Steve R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682451/ https://www.ncbi.nlm.nih.gov/pubmed/23772298 http://dx.doi.org/10.4081/rt.2013.e12 |
Ejemplares similares
-
Intact parathyroid hormone and whole parathyroid hormone assay results disagree in hemodialysis patients under cinacalcet hydrochloride therapy
por: Koda, Ryo, et al.
Publicado: (2014) -
Diagnostic Accuracy of Intraoperative Intact Parathyroid Hormone Monitoring for Surgical Outcomes of Secondary Hyperparathyroidism
por: Chen, Yuanyuan, et al.
Publicado: (2021) -
Malignant Hypercalcemia Induced by the Ectopic Production of Intact Parathyroid Hormone (PTH)
por: Neves, Ana, et al.
Publicado: (2023) -
The value of intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and varying baseline parathyroid hormone levels
por: Hargitai, Lindsay, et al.
Publicado: (2022) -
Intrathyroidal Parathyroid Carcinoma Presenting as Asymptomatic High Normal Serum Calcium and Slightly Elevated Intact Parathyroid Hormone: A Case Report and Review of Literature
por: Quartey, Benjamin, et al.
Publicado: (2011)